XT
SEEL

XTX Topco’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

XTX Topco’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-126
Closed -$9.5K – 2604
2024
Q1 		$9.5K Buy
+126
New +$16.6K ﹤0.01% 1677
2023
Q4 		– Sell
-26
Closed -$18.3K – 2267
2023
Q3 		$18.3K Buy
+26
New +$111K ﹤0.01% 1384
2021
Q3 		– Sell
-3
Closed -$29K – 1133
2021
Q2 		$29K Sell
3
-9
-75% -$148K 0.01% 751
2021
Q1 		$222K Buy
+12
New +$140K 0.11% 451

Other funds holding SEEL

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $8.34B AUM 19.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CHA
Carmichael Hill & Associates Gaithersburg, Maryland $282M AUM 32.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

XTX Topco's SEEL Position: Q2 2024 in Review

XTX Topco sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q2 2024, closing a stake of 126 shares — an estimated $9.5K sold.

XTX Topco first reported a position in SEEL in Q1 2021 and held it in 4 quarters. The position peaked at $222K in Q1 2021. 18 funds tracked by Wall St. Rank hold SEEL as of Q2 2024.

  • XTX Topco reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • XTX Topco sold 126 Seelos Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $9.5K.
  • XTX Topco first reported a position in Seelos Therapeutics, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
  • XTX Topco's Seelos Therapeutics, Inc. Common Stock position peaked at $222K in Q1 2021.
  • 18 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q2 2024.

Based on XTX Topco's 13F filing for Q2 2024, filed 12 Aug 2024.